Eli Lilly and Company

LLY.MX·Mexico·Healthcare
Compare
26,360.00−472.84 (−1.76%)today
At close: Nov 4, 2:09 PM CST · May be delayed up to 20 min · MXN

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close26,832.84
Open26,500.00
Day range26,295.0026,595.00
52-week range14,915.0026,913.16
Off day high−0.88%
Off 52-week high−2.06%
Volume1.09K
Avg. volume (3M)863
Market cap23.48T
EPS (TTM)543.81
Forward P/E—
P/E ratio (TTM)48.47
Dividend yield0.49% (130.26)
Beta (5Y)0.39
Shares outstanding890.75M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin31.90%

Against its peers

Compare in full ›
LLY.MX 0QCV.IL BMY BIIB 0QYQ.IL AZN
Market cap 23.48T 536.09B 131.21B 37.61B 217.96B 293.14B
P/E (TTM) 48.5 61.3 14.2 110.2 40.2 26.7
Forward P/E — — 9.6 15.6 — 16.7
Price/book 31.2 40.9 5.6 2.0 10.3 5.7
Dividend yield 0.49% 4.05% 3.93% — 3.81% 1.69%
1-year change +51.43% +30.72% +37.66% +62.35% +40.64% +12.81%
Today −1.76% +4.93% +4.02% +2.22% +1.70% +2.79%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Latest news

All LLY.MX news ›
Sports Business Journal·Positive

Excel Sports Management adds key accounts with Deloitte, Eli Lilly

Sports Business Journal Excel Sports Management adds key accounts with Deloitte, Eli Lilly Acclamation should be extended to Excel Sports Management for noteworthy agency of record wins in two recent RFPs. Industry sources tell us E

LLY
Devdiscourse·

Reuters Health News Summary

AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter.…

Seeking Alpha·Positive

Eli Lilly: Higher Volume, Lower Realized Prices

Pharmaceutical company Eli Lilly and Company (LLY) reported volume growth of 53% last quarter against a 15% decline in realized prices. Revenue rose 39%. Gross margin went up year-over-year, too. That combination is unusual Best Stocks Now…

The Motley Fool·Positive

Pharming: 3 Key Takeaways for Long-Term Investors

A rare-disease player with a stabilized core product is now targeting a market 26 times larger, fueled by cash generation that needs no external financing. On its third-quarter 2026 earnings call, held on Oct. 27, 2026, Pharming (PHAR…

Trefis·Negative

Is Eli Lilly Stock Increasing Your Market Risk?

Eli Lilly Stock Has Barely Followed The Market No, not over the past year. Between October 31, 2025, and November 3, 2026, the S&P 500 lost 0.606% on the average day it fell, while a $10,000 holding of Lilly stock gained about $15.70. On…

From the 4Search news index, newest first.

In the news

1,480mentions in 30 days
362with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance